Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126967751 | 12696775 | 1 | I | 20160115 | 0 | 20160829 | 20160829 | DIR | 61.00 | YR | M | N | 125.00000 | LBS | 20160820 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126967751 | 12696775 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75MG 1 PILL ONCE DAILY BY MOUTH | N | FK032A/1289201A0 | 20170520 | 0 | 75 | MG | QD | ||||
| 126967751 | 12696775 | 3 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 126967751 | 12696775 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126967751 | 12696775 | 7 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 126967751 | 12696775 | 9 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 126967751 | 12696775 | 11 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 126967751 | 12696775 | 13 | C | DOCUSATE | DOCUSATE | 1 | 0 | ||||||||||||
| 126967751 | 12696775 | 15 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 126967751 | 12696775 | 17 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 126967751 | 12696775 | 19 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 0 | ||||||||||||
| 126967751 | 12696775 | 21 | C | POTASSIUM | POTASSIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126967751 | 12696775 | 1 | Anticoagulant therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126967751 | 12696775 | HO |
| 126967751 | 12696775 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126967751 | 12696775 | Asthenia | |
| 126967751 | 12696775 | Confusional state | |
| 126967751 | 12696775 | Contusion | |
| 126967751 | 12696775 | Decreased appetite | |
| 126967751 | 12696775 | Dyspnoea | |
| 126967751 | 12696775 | Gastric haemorrhage | |
| 126967751 | 12696775 | Haemoptysis | |
| 126967751 | 12696775 | Headache | |
| 126967751 | 12696775 | Peripheral swelling | |
| 126967751 | 12696775 | Skin atrophy | |
| 126967751 | 12696775 | Skin discolouration | |
| 126967751 | 12696775 | Skin haemorrhage | |
| 126967751 | 12696775 | Yellow skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126967751 | 12696775 | 1 | 20160116 | 20160802 | 0 |